Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.
Department of Internal Medicine, College of Physicians and Surgeons of Columbia University, and New York Presbyterian Hospital, New York, New York 10032, USA.
Angelo B
AB
Biviano
LeRoy E
LE
Rabbani
Furcy
F
Paultre
Eileen
E
Hurley
Jennifer
J
Sullivan
James
J
Giglio
Lori
L
Mosca
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003325:Coronary Care Units / Q000592:standards*; D019091:Critical Pathways; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D010349:Patient Compliance; D010353:Patient Education as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D015397:Program Evaluation; D012189:Retrospective Studies
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin